Ending the year in debate

Article

The holiday season is upon us again and we are about to close the door on another year, but before we do, I would firstly like to say a big thank you to all of you for your continued support of our publication throughout this year.

The holiday season is upon us again and we are about to close the door on another year, but before we do, I would firstly like to say a big thank you to all of you for your continued support of our publication throughout this year. The OTE team and I have really enjoyed working with you and meeting with you while we've been out and about, and we look forward to doing so in 2009.

But before we say goodbye to 2008, we have a real treat in store for you. We are ending the year with a series of debates on some of the most controversial topics in ophthalmology. The 2008 debates series raises important issues that made it to the podium this year. So have a look at our debates to read what some of the world's eminent surgeons had to say when they came head-to-head on some of the most important issues in your industry.

On a separate note, I would like to take this opportunity to announce that we are about to have a facelift! Yes, the first issue of OTE in 2009 will have a new look. We're going for a new size issue that will be packed with more content than before. We've also changed our weekly e-newsletter, which will be going out on Wednesdays rather than Mondays. If you've not subscribed already, just go to www.oteurope.com/enews to take advantage of this free, weekly breaking news service. We hope you like the changes. As always, I would be really happy to hear your thoughts so please do drop me an email to let me know what you think.

Thank you once again for another great year. Let's enter 2009 with optimism and hope for continued successes. I know I will!

Happy holidays everyone.

Best wishes,

Fedra Pavlou
Editor
[email protected]

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.